X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (163) 163
Publication (47) 47
Patent (40) 40
Conference Proceeding (8) 8
Book Review (4) 4
Dissertation (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (86) 86
humans (72) 72
female (54) 54
oncology (52) 52
article (47) 47
middle aged (34) 34
male (31) 31
cancer (26) 26
prognosis (25) 25
aged (23) 23
animals (23) 23
breast cancer (23) 23
expression (23) 23
adult (21) 21
electricity (21) 21
mice (21) 21
basic electric elements (18) 18
devices using stimulated emission (18) 18
neoplasm staging (17) 17
survival (16) 16
breast neoplasms - drug therapy (14) 14
breast neoplasms - pathology (14) 14
chemotherapy (14) 14
risk factors (13) 13
tumors (13) 13
breast neoplasms - genetics (12) 12
breast neoplasms - metabolism (11) 11
cell biology (11) 11
research (11) 11
analysis (10) 10
disease-free survival (10) 10
gene expression (10) 10
gene expression profiling (10) 10
kaplan-meier estimate (10) 10
aged, 80 and over (9) 9
cell proliferation (9) 9
physics (9) 9
research article (9) 9
surgery (9) 9
treatment outcome (9) 9
biomarkers, tumor - analysis (8) 8
care and treatment (8) 8
cell line, tumor (8) 8
gene expression regulation, neoplastic (8) 8
mutation (8) 8
tamoxifen (8) 8
biomarkers (7) 7
brain neoplasms - pathology (7) 7
breast-cancer (7) 7
clinical trials (7) 7
endocrine therapy (7) 7
epidemiology (7) 7
estrogen (7) 7
health aspects (7) 7
immunohistochemistry (7) 7
in-vivo (7) 7
measuring (7) 7
mice, inbred c57bl (7) 7
multidisciplinary sciences (7) 7
pathology (7) 7
predictive value of tests (7) 7
prevention (7) 7
proportional hazards models (7) 7
statistics & probability (7) 7
testing (7) 7
anastrozole (6) 6
blasting (6) 6
case-control studies (6) 6
cells, cultured (6) 6
development and progression (6) 6
gene (6) 6
genes (6) 6
genetic aspects (6) 6
growth (6) 6
heating (6) 6
hematology (6) 6
investigating or analysing materials by determining theirchemical or physical properties (6) 6
lighting (6) 6
mechanical engineering (6) 6
medical colleges (6) 6
medicine (6) 6
medicine & public health (6) 6
p16 (6) 6
patients (6) 6
positive displacement machines for liquids (6) 6
power (6) 6
pumps for liquids or elastic fluids (6) 6
receptors, estrogen - metabolism (6) 6
retrospective studies (6) 6
science (6) 6
weapons (6) 6
young adult (6) 6
abridged index medicus (5) 5
antineoplastic agents - pharmacology (5) 5
biomarkers, tumor - genetics (5) 5
biomarkers, tumor - metabolism (5) 5
brain neoplasms - metabolism (5) 5
carcinoma (5) 5
carcinoma, squamous cell - virology (5) 5
chemistry (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the National Cancer Institute, ISSN 0027-8874, 10/2008, Volume 100, Issue 19, pp. 1380 - 1388
Journal Article
Nature, ISSN 0028-0836, 06/2012, Volume 486, Issue 7403, pp. 353 - 360
Journal Article
Journal Article
Journal Article
Journal of Statistical Software, ISSN 1548-7660, 2012, Volume 51, Issue 3, pp. 1 - 24
Medical researchers endeavor to identify potentially useful biomarkers to develop marker based screening assays for disease diagnosis and prevention. Useful... 
Three ordinal groups | Diagnostic test | Youden index | Volume under the ROC surface | DiagTest3Grp | COMPUTER SCIENCE, INTERDISCIPLINARY APPLICATIONS | volume under the ROC surface | ROC CURVE | STATISTICS & PROBABILITY | AREAS | diagnostic test | three ordinal groups | OPERATING CHARACTERISTIC CURVES | ACCURACY
Journal Article
Cell Reports, ISSN 2211-1247, 09/2013, Volume 4, Issue 6, pp. 1116 - 1130
Journal Article
Immunity, ISSN 1074-7613, 08/2017, Volume 47, Issue 2, pp. 323 - 338.e6
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 08/2017, Volume 23, Issue 15, pp. 4055 - 4065
Purpose: Cyclin-dependent kinase (CDK) 4/6 drives cell proliferation in estrogen receptor-positive (ER+) breast cancer. This single-arm phase II neoadjuvant... 
TRIAL | AROMATASE INHIBITOR | 1ST-LINE TREATMENT | RETINOBLASTOMA PROTEIN | ONCOLOGY | INTRINSIC SUBTYPE | IN-VIVO | DOUBLE-BLIND | LETROZOLE | CELL-PROLIFERATION | POSTMENOPAUSAL WOMEN | Cyclin-Dependent Kinase 6 - antagonists & inhibitors | Piperazines - administration & dosage | Breast Neoplasms - surgery | Triazoles - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Class I Phosphatidylinositol 3-Kinases - genetics | Receptor, ErbB-2 - genetics | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Nitriles - administration & dosage | Pyridines - adverse effects | Adult | Female | Neoadjuvant Therapy | Gene Expression Regulation, Neoplastic - drug effects | Cyclin-Dependent Kinase 4 - antagonists & inhibitors | Pyridines - administration & dosage | Breast Neoplasms - drug therapy | Piperazines - adverse effects | Disease-Free Survival | Breast Neoplasms - genetics | Estrogen Receptor alpha - genetics | Breast Neoplasms - pathology | Aged | Cell Proliferation - drug effects | Mutation | Neoplasm Staging | Cell proliferation | Anastrozole | Estrogens | Cyclin-dependent kinases | Estrogen | Estrogen receptors | Breast cancer | Kinases | Gene expression | Patients | ErbB-2 protein | Cyclin-dependent kinase 4 | Cyclin-dependent kinase | E2F protein | Inhibitors | Experimental design | Surgery | Cell cycle | Breast | Cancer | Index Medicus | breast cancer | neoadjuvant | anastrozole | CDK4 | palbociclib
Journal Article
Journal of Statistical Software, ISSN 1548-7660, 2012, Volume 51, Issue 3
Journal Article